Correction: Kao et al. RNF8-CDH1 Co-Expression Predicts Clinical Benefit of Chemoradiotherapy in Triple-Negative Breast Cancer. J. Pers. Med. 2021, 11, 655

J Pers Med. 2022 Mar 15;12(3):466. doi: 10.3390/jpm12030466.

Authors

Chieh-Ni Kao^{1

2}, Sin-Hua Moi³, Ming-Feng Hou², Chi-Wen Luo², Fang-Ming Chen², Mei-Ren Pan^{1

4}

Affiliations

¹ Graduate Institute of Clinical Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
² Division of Breast Oncology and Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan.
³ Center of Cancer Program Development, E-Da Cancer Hospital, I-Shou University, Kaohsiung 824, Taiwan.
⁴ Drug Development and Value Creation Research Center, Kaohsiung Medical University, Kaohsiung 807, Taiwan.

Abstract

The authors would like to make corrections to a recently published paper [...].

Publication types

Published Erratum